vs
Side-by-side financial comparison of Okeanis Eco Tankers Corp. (ECO) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Okeanis Eco Tankers Corp. is the larger business by last-quarter revenue ($393.2M vs $207.8M, roughly 1.9× IDEAYA Biosciences, Inc.).
Okeanis Eco Tankers Corp. is a global shipping enterprise specializing in the operation of eco-friendly tanker fleets. Its core business covers maritime transport of crude oil and refined petroleum products, serving major energy and commodity clients across key international trade routes, with a focus on cutting carbon emissions via energy-efficient vessel designs.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
ECO vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $393.2M | $207.8M |
| Net Profit | — | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 41.4% | 52.2% |
| Net Margin | — | 57.4% |
| Revenue YoY | — | — |
| Net Profit YoY | — | 330.1% |
| EPS (diluted) | — | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $393.2M | — | ||
| Q3 25 | $308.0M | $207.8M | ||
| Q2 25 | $-49.0M | — | ||
| Q1 25 | $111.1M | — | ||
| Q4 24 | $413.1M | — | ||
| Q3 24 | $321.4M | $0 | ||
| Q2 24 | $232.4M | $0 | ||
| Q1 24 | — | $0 |
| Q4 25 | — | — | ||
| Q3 25 | — | $119.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-51.8M | ||
| Q2 24 | — | $-52.8M | ||
| Q1 24 | — | $-39.6M |
| Q4 25 | 41.4% | — | ||
| Q3 25 | 44.2% | 52.2% | ||
| Q2 25 | 101.1% | — | ||
| Q1 25 | 49.6% | — | ||
| Q4 24 | 48.7% | — | ||
| Q3 24 | 52.0% | — | ||
| Q2 24 | 56.7% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 57.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.33 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.60 | ||
| Q2 24 | — | $-0.68 | ||
| Q1 24 | — | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $116.6M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $573.1M | $1.1B |
| Total Assets | $1.2B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $116.6M | — | ||
| Q3 25 | — | $786.9M | ||
| Q2 25 | $59.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $49.3M | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | $92.8M | $701.7M | ||
| Q1 24 | — | $698.8M |
| Q4 25 | $573.1M | — | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | $428.3M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $410.4M | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $432.6M | $931.7M | ||
| Q1 24 | — | $935.3M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $1.1B | $973.7M | ||
| Q1 24 | — | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $111.3M | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $111.3M | — | ||
| Q3 25 | $132.2M | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | — | $-49.2M | ||
| Q2 24 | — | $-32.9M | ||
| Q1 24 | — | $-43.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
